CAPTRUST Financial Advisors’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-429
| Closed | -$1K | – | 2497 |
|
|
2022
Q2 | $1K | Sell |
429
-735
| -63% | -$1.71K | ﹤0.01% | 4655 |
|
|
2022
Q1 | $3K | Buy |
1,164
+164
| +16% | +$423 | ﹤0.01% | 4344 |
|
|
2021
Q4 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 4168 |
|
|
2021
Q3 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 3936 |
|
|
2021
Q2 | $6K | Buy |
1,000
+300
| +43% | +$1.8K | ﹤0.01% | 3772 |
|
|
2021
Q1 | $5K | Buy |
+700
| New | +$5K | ﹤0.01% | 3720 |
|